Company Filing History:
Years Active: 2018-2020
Title: Alfred Zochling: Innovator in Coagulation Factor Inactivation
Introduction
Alfred Zochling is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biochemistry, particularly in the area of coagulation factors. With a total of 2 patents, Zochling's work has the potential to impact medical practices related to blood coagulation.
Latest Patents
Zochling's latest patents focus on methods for the inactivation or removal of coagulation factors. One of his key inventions is a method for inactivation or removal of coagulation factors FII, FVII, FVIIa, FIX, FIXa, FX, FXI, and FXIa in or from protein-containing solutions obtained from blood, blood plasma, or plasma fractions. This method involves contacting the protein-containing solution with an organic acid or its salt while being stirred, which enhances the efficiency of the process.
Career Highlights
Alfred Zochling is associated with Octapharma AG, a company known for its innovative approaches in the field of human proteins. His work at Octapharma has allowed him to develop and refine his patented methods, contributing to advancements in therapeutic solutions.
Collaborations
Zochling collaborates with talented professionals in his field, including Waltraud Kaar and Karin Ahrer. These collaborations foster an environment of innovation and shared expertise, further enhancing the impact of their work.
Conclusion
Alfred Zochling's contributions to the field of coagulation factor inactivation demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic methods for blood-related conditions.